Search results for "" 1588 results found

• IP Cases & Articles

  CJEU C-34/10 - European Stem Cell Industry

  Posted on 01 December 2011
  Replacement neurons to treat spinal cord injury, insulin-producing cells to treat diabetes, dopamine-producing neurons to treat Parkinson’s disease... the possibilities are endless. As embryonic stem cells are undifferentiated, they theoretically have the ability to develop into any one of the specialised cell or tissue types found in the human body.…
• IP Cases & Articles

  Scope of Mental Act Exclusion Clarified and Reduced

  Posted on 01 December 2011
  In a recent case, Halliburton 2011, the UK Courts have significantly clarified (and reduced) the scope of the mental act exclusion in UK patent law.
• IP Cases & Articles

  Vacuum Cleaner 'Wars' - Dyson v Vax

  Posted on 15 November 2011
  The UK Court of Appeal handed down a decision on 27 October 2011 that provides some useful guidance regarding construing the scope of a national UK registered design.
• IP Cases & Articles

  Generic Top Level Domains (gTLDs) - New Challenges

  Posted on 01 November 2011
  On 20 June 2011, following a long period of consultation with relevant stakeholders, the Internet Corporation for Assigned Names and Numbers (ICANN) announced its decision to open the internet’s naming system and allow any interested organisation (whether private or public) to apply to register new gTLDs and to become operators…
• IP Cases & Articles

  Generics UK (Mylan) v Novartis: EWHC 2403 Rivastigmine

  Posted on 21 October 2011
  The High Court has recently handed down judgment resulting in the revocation of the Novartis patent and SPC relating to rivastigmine (Exelon®). This is a further action where the Court was faced with a patent relating to the resolved enantiomer of a prior art racemic compound. Unlike the previous occasions,…
• IP Cases & Articles

  CJEU Stem Cell Patents: Br��stle v Greenpeace (C-34/10)

  Posted on 18 October 2011
  The Court of Justice of the European Union (CJEU) today issued its decision in Brüstle v Greenpeace (C-34/10) which relates to the patentability of technology based on the use of human embryonic stem cells (hESC).
• IP Cases & Articles

  MedImmune v Novartis: Obviousness and Lack of Priority��

  Posted on 03 October 2011
  The judgment by Mr Justice Arnold runs to 161 pages, and relates to a large family of patents jointly owned by MedImmune and MRC, which were directed to antibody phage display technology. Allegedly these patents were infringed by Novartis’ sale of Lucentis (chemically named ranibizumab), which is a treatment for…
• IP Cases & Articles

  Interflora v Marks & Spencer: Online Keywords Dispute

  Posted on 23 September 2011
  Marks & Spencer had previously made use of Google’s Adwords facility to select the name ‘Interflora’ (in a variety of spellings) to promote its own retail flower services. When a Google user typed ‘Interflora’ into its search engine, an advertisement for the services provided by Marks & Spencer was displayed…
• IP Cases & Articles

  Patenting Genes and Diagnostics

  Posted on 11 September 2011
  This article was originally published by Life Sciences Intellectual Property Review.
  

  Simon O'Brien

  Partner, Patent Attorney
• IP Cases & Articles

  Myriad: Association for Molecular Pathology

  Posted on 09 August 2011
  On 29 July 2011, the Federal Circuit issued its much anticipated decision on the ‘Myriad case’. The court held that that claims directed to isolated DNA were patent eligible but diagnostic claims that relate to ‘comparing’ or ‘analysing’ sequences were patent ineligible.
  

  Simon O'Brien

  Partner, Patent Attorney

Page 153 of 159